Tami Tillotson Martin

Insider Reports History

Entity
Individual
Location
C/O Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD
Signature
/s/ Timothy C. Dec, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tami Tillotson Martin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SUPERNUS PHARMACEUTICALS, INC. Sr. V.P., Regulatory Affairs Common Stock 86.9K $2.53M $29.06 Feb 23, 2024 Direct
SUPERNUS PHARMACEUTICALS, INC. Sr. V.P., Regulatory Affairs Restricted Stock Unit 3.75K $105K $27.94 Feb 23, 2024 Direct
SUPERNUS PHARMACEUTICALS, INC. Sr. V.P., Regulatory Affairs Employee Stock Option (Right to Buy) 0 Jan 10, 2024 Direct

Insider Reports Filed by Tami Tillotson Martin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 23, 2024 3 -$14.1K 4 Feb 27, 2024 Sr. V.P., Regulatory Affairs
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2024 3 -$6.87K 4 Feb 26, 2024 Sr. V.P., Regulatory Affairs
SUPN SUPERNUS PHARMACEUTICALS, INC. Jan 10, 2024 3 -$149K 4 Jan 12, 2024 Sr. V.P., Regulatory Affairs
SUPN SUPERNUS PHARMACEUTICALS, INC. Aug 30, 2023 3 -$64.9K 4 Sep 1, 2023 Sr. V.P., Regulatory Affairs
SUPN SUPERNUS PHARMACEUTICALS, INC. Aug 25, 2023 1 -$162K 4 Aug 29, 2023 Sr. V.P., Regulatory Affairs
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 23, 2023 2 $0 4 Feb 27, 2023 Sr. V.P., Regulatory Affairs
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2023 3 -$11.1K 4/A Apr 12, 2023 Sr. V.P., Regulatory Affairs
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 16, 2023 2 $0 4 Feb 21, 2023 Sr. V.P., Regulatory Affairs
SUPN SUPERNUS PHARMACEUTICALS, INC. Jan 12, 2023 1 $0 4 Jan 17, 2023 Sr. V.P., Regulatory Affairs
SUPN SUPERNUS PHARMACEUTICALS, INC. Aug 22, 2022 3 -$140K 4 Aug 23, 2022 Sr. V.P., Regulatory Affairs
SUPN SUPERNUS PHARMACEUTICALS, INC. Aug 4, 2022 3 -$125K 4 Aug 5, 2022 Sr. V.P., Regulatory Affairs
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2022 2 $0 4/A Feb 25, 2022 Sr. V.P., Regulatory Affairs